+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pediatric Vaccines Market Research Report by Technology (Attenuated Live Viruses, Conjugates, and Inactivated Viruses), Vaccine Type, End User, Indication, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968566
  • Report
  • April 2022
  • Region: Global
  • 216 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AstraZeneca PLC
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Merck Sharp & Dohme Corp.
  • Novartis AG
The Global Pediatric Vaccines Market size was estimated at USD 15.38 billion in 2021, USD 17.12 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.46% to reach USD 29.51 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
  • Based on Vaccine Type, the market was studied across Monovalent and Multivalent.
  • Based on End User, the market was studied across Hospital, Pediatric Clinic, and Research Organization.
  • Based on Indication, the market was studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pediatric Vaccines market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pediatric Vaccines Market, including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Pediatric Vaccines Market?
6. What is the market share of the leading vendors in the Global Pediatric Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Pediatric Vaccines Market?
Frequently Asked Questions about the Global Pediatric Vaccines Market

What is the estimated value of the Global Pediatric Vaccines Market?

The Global Pediatric Vaccines Market was estimated to be valued at $15.4 Billion in 2021.

What is the growth rate of the Global Pediatric Vaccines Market?

The growth rate of the Global Pediatric Vaccines Market is 11.4%, with an estimated value of $29.5 Billion by 2027.

What is the forecasted size of the Global Pediatric Vaccines Market?

The Global Pediatric Vaccines Market is estimated to be worth $29.5 Billion by 2027.

Who are the key companies in the Global Pediatric Vaccines Market?

Key companies in the Global Pediatric Vaccines Market include AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc. and Serum Institute of India Pvt. Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca PLC
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Merck Sharp & Dohme Corp.
  • Novartis AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
5.1.1.3. Government intervention for the use of pediatric vaccines
5.1.2. Restraints
5.1.2.1. Lack of implementation of mandatory vaccination
5.1.2.2. Slight-side effects associated with pediatric vaccines
5.1.3. Opportunities
5.1.3.1. Strong late-stage pipeline and new drug approvals
5.1.3.2. Routinized vaccines used in immunization of infants and children
5.1.4. Challenges
5.1.4.1. No uniform recall or reminder system and staff shortages
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids
7. Pediatric Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Multivalent
8. Pediatric Vaccines Market, by End User
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization
9. Pediatric Vaccines Market, by Indication
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever
10. Americas Pediatric Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pediatric Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pediatric Vaccines Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AstraZeneca PLC
14.2. CSL Limited
14.3. Eli Lilly and Company
14.4. GlaxoSmithKline PLC
14.5. Merck Sharp & Dohme Corp.
14.6. Mitsubishi Chemical Corporation
14.7. Novartis AG
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PEDIATRIC VACCINES MARKET: DYNAMICS
FIGURE 2. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (%)
FIGURE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2027
FIGURE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2027
FIGURE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 36. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2027
FIGURE 38. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2019-2027 (USD BILLION)
FIGURE 43. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 44. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2019-2027 (USD BILLION)
FIGURE 45. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2019-2027 (USD BILLION)
FIGURE 47. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 48. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2019-2027 (USD BILLION)
FIGURE 49. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 50. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2019-2027 (USD BILLION)
FIGURE 51. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 52. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2019-2027 (USD BILLION)
FIGURE 53. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 54. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2019-2027 (USD BILLION)
FIGURE 55. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 56. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2019-2027 (USD BILLION)
FIGURE 57. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 58. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2019-2027 (USD BILLION)
FIGURE 59. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 60. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2019-2027 (USD BILLION)
FIGURE 61. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 62. AMERICAS PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. BRAZIL PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. CANADA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. MEXICO PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. INDIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. INDONESIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. JAPAN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. TAIWAN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. THAILAND PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. FRANCE PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. GERMANY PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. ITALY PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. QATAR PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. RUSSIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 87. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 88. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 89. SPAIN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 91. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 92. GLOBAL PEDIATRIC VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 93. GLOBAL PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 94. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PEDIATRIC VACCINES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PEDIATRIC VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 67. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY STATE, 2019-2027 (USD BILLION)
TABLE 70. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 73. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY REGION, 2019-2027 (USD BILLION)
TABLE 78. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY STATE, 2019-2027 (USD BILLION)
TABLE 80. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 83. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2019-2027 (USD BILLION)
TABLE 88. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY STATE, 2019-2027 (USD BILLION)
TABLE 90. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 92. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2019-2027 (USD BILLION)
TABLE 93. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY STATE, 2019-2027 (USD BILLION)
TABLE 95. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 97. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 98. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 99. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 100. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 102. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2019-2027 (USD BILLION)
TABLE 103. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 104. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY STATE, 2019-2027 (USD BILLION)
TABLE 105. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 107. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2019-2027 (USD BILLION)
TABLE 108. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 109. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY STATE, 2019-2027 (USD BILLION)
TABLE 110. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 112. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2019-2027 (USD BILLION)
TABLE 113. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 114. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY STATE, 2019-2027 (USD BILLION)
TABLE 115. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 117. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2019-2027 (USD BILLION)
TABLE 118. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 119. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY STATE, 2019-2027 (USD BILLION)
TABLE 120. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 122. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2019-2027 (USD BILLION)
TABLE 123. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 124. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY STATE, 2019-2027 (USD BILLION)
TABLE 125. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 127. AMERICAS PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. BRAZIL PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 130. CANADA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 131. MEXICO PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. CHINA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. INDIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 137. INDONESIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. JAPAN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 139. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 142. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 143. TAIWAN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. THAILAND PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 146. FRANCE PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. GERMANY PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 148. ITALY PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 149. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 150. QATAR PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 151. RUSSIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 152. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 153. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 154. SPAIN PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 155. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 156. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 157. GLOBAL PEDIATRIC VACCINES MARKET: SCORES
TABLE 158. GLOBAL PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 159. GLOBAL PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 160. GLOBAL PEDIATRIC VACCINES MARKET: RANKING
TABLE 161. GLOBAL PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 162. GLOBAL PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 163. GLOBAL PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 164. GLOBAL PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 165. GLOBAL PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 166. GLOBAL PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 167. GLOBAL PEDIATRIC VACCINES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AstraZeneca PLC
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Merck Sharp & Dohme Corp.
  • Mitsubishi Chemical Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...